ログインで組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
| 容量 | カタログ番号 | 在庫状況 | 単価 |
|---|---|---|---|
| 25 g | カートの在庫状況を確認する | ¥9,270 | |
| 100 g | カートの在庫状況を確認する | ¥31,700 |
この商品について
化学式:
CH3C(=NOH)COCH3
CAS番号:
分子量:
101.10
UNSPSC Code:
41116105
NACRES:
NA.21
PubChem Substance ID:
EC Number:
200-348-5
Beilstein/REAXYS Number:
605582
MDL number:
Quality Level
assay
≥98.0% (N), ≥99.0%
form
solid
quality
for spectrophotometric det. of urea
technique(s)
UV/Vis spectroscopy: suitable
ign. residue
≤0.05% (as SO4)
bp
185-186 °C (lit.)
mp
75-76 °C, 75-78 °C (lit.)
SMILES string
CC(=O)\C(C)=N\O
InChI
1S/C4H7NO2/c1-3(5-7)4(2)6/h7H,1-2H3/b5-3+
InChI key
FSEUPUDHEBLWJY-HWKANZROSA-N
General description
2,3-Butanedione Monoxime (BDM) is also known as diacetyl monoxime, it is also a nucleophilic agent and it can dephosphorylates acetylcholinesterase poisoned with organophosphates. It is also a well-characterized, non-competitive inhibitor of skeletal muscle myosin-II, where it inhibits the chemical and motile activity.
Application
- A novel method to extend viability and functionality of living heart slices.: This research introduces a novel application of 2,3-Butanedione monoxime for prolonging the functional lifespan of cardiac tissue samples in experimental settings, offering insights into cardiac biology and potential therapeutic targets (Ross et al., 2023).
- Molecular Mechanisms of Deregulation of Muscle Contractility Caused by the R168H Mutation in TPM3 and Its Attenuation by Therapeutic Agents.: The study utilizes 2,3-Butanedione monoxime to investigate the molecular pathways affected by genetic mutations in muscle contractility, contributing to the understanding of muscle disorders and their management (Karpicheva et al., 2023).
- Generation of myocyte agonal Ca(2+) waves and contraction bands in perfused rat hearts following irreversible membrane permeabilisation.: Research employing 2,3-Butanedione monoxime investigates its role in inducing specific cellular events in cardiac cells under stress, highlighting its potential in studies of heart disease mechanisms and therapies (Morishita et al., 2023).
Analysis Note
溶解度:
10 mLの水または10 mLのエタノールに0.5 gが完全に溶解し、透明溶液となります。
感度分析:
0.05 mgの尿素を3 mLの水、5 mL濃塩酸、3%ジアセチルモノキシム水溶液とともに水浴で10分間加熱すると、淡黄色の溶液が得られます。
10 mLの水または10 mLのエタノールに0.5 gが完全に溶解し、透明溶液となります。
感度分析:
0.05 mgの尿素を3 mLの水、5 mL濃塩酸、3%ジアセチルモノキシム水溶液とともに水浴で10分間加熱すると、淡黄色の溶液が得られます。
Other Notes
Reagent for the colorimetric determination of urea and ureido-compounds; Spectrometric reagent for Co(II), Ni(II), Pd(II) and Re(VII); Reagent for the gravimetric determination of Ni(II)
1 of 1
当該品目 | |||
|---|---|---|---|
| assay ≥98.0% (N), ≥99.0% | assay ≥98% | assay ≥98% (GC) | assay 97% |
| Quality Level 100 | Quality Level 200 | Quality Level 100 | Quality Level 100 |
| technique(s) UV/Vis spectroscopy: suitable | technique(s) - | technique(s) - | technique(s) - |
| bp 185-186 °C (lit.) | bp 185-186 °C (lit.) | bp - | bp 88 °C (lit.) |
| quality for spectrophotometric det. of urea | quality - | quality - | quality - |
| mp 75-76 °C, 75-78 °C (lit.) | mp 75-78 °C (lit.) | mp - | mp - |
Still not finding the right product?
Explore all of our products under 2,3-ブタンジオンモノオキシム
保管分類
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
2, 3-Butanedione monoxime (BDM) as a myosin inhibitor.
Ostap EM.
Journal of Muscle Research and Cell Motility, 23 (4), 305-308 (2002)
Multiple Effects of 2, 3-Butanedione Monoxime.
Sellin LC and McArdle JJ/
Pharmacology & Toxicology, 74 (4-5), 305-313 (1994)
W.B. Guenther
Analytical Letters, 12A, 1305-1305 (1979)
グローバルトレードアイテム番号
| カタログ番号 | GTIN |
|---|---|
| 31550-100G | 04061826689776 |
| 31550-25G | 04061826689783 |
| 31550-500G | 04061826689790 |


